Fuller & Thaler Asset Management
CMD

Fuller & Thaler Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Fuller & Thaler Asset Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-800
Closed -$79K – 772
2018
Q2 		$79K Hold
800
– – ﹤0.01% 614
2018
Q1 		$89K Buy
+800
New +$89.7K ﹤0.01% 560
2015
Q4 		– Sell
-700
Closed -$40K – 782
2015
Q3 		$40K Buy
+700
New +$37.1K ﹤0.01% 603

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fuller & Thaler Asset Management's CMD Position: Q3 2018 in Review

Fuller & Thaler Asset Management sold out of Cantel Medical Corporation (CMD) in Q3 2018, closing a stake of 800 shares — an estimated $79K sold.

Fuller & Thaler Asset Management first reported a position in CMD in Q3 2015 and held it in 3 quarters. The position peaked at $89K in Q1 2018. 286 funds tracked by Wall St. Rank hold CMD as of Q3 2018.

  • Fuller & Thaler Asset Management reported no remaining Cantel Medical Corporation position as of Q3 2018 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 800 Cantel Medical Corporation shares in Q3 2018, an estimated $79K.
  • Fuller & Thaler Asset Management first reported a position in Cantel Medical Corporation in Q3 2015 and held it in 3 quarters.
  • Fuller & Thaler Asset Management's Cantel Medical Corporation position peaked at $89K in Q1 2018.
  • 286 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2018.

Based on Fuller & Thaler Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.